SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZTC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (721)11/8/2000 10:48:23 AM
From: Biomaven  Read Replies (2) of 752
 
That's not good news. The fairly significant delay in ATIII and the need to find a new partner will probably mean a need for more funding, and given GENZ has been selling some shares anyhow, they may not be the best source.

I sold my holding at the open today - a little reluctantly, because I still think that long term this will be a good way to produce Mabs. However, the ATIII delay will also probably delay the willingness of Mab partners to sign up - having a product already on the market would have provided some security that the process produces approvable products.

The one good thing here is that this will serve to further disentangle the company from GENZ.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News